CMS has proposed that non-disable, under age 65 year old kidney transplants have lifetime coverage under Part B for immunosuppressives instead of the 36-month limit currently.

Proposal to Increase CMS Coverage for Immunosuppressive Drugs following Transplants under Part B to Lifetime Coverage

<p>Pharmacy Revenue Cycle News aims to provide you with helpful tips, resources, and emerging updates that can improve your pharmacy revenue. We have one very simple goal. We take complex and ever changing rules and regulations to bring you awareness and practical tools that can help you understand and enhance your pharmacy revenue cycle. Our website is full of resources, tools, explanations and links that can help you navigate the pharmacy revenue cycle. Each newsletter provides you with practical tips for you to put into practice.</p>

Business

Medicine

Health & Fitness

Government

Pharmacy Revenue Cycle News aims to provide you with helpful tips, resources, and emerging updates that can improve your pharmacy revenue. We have one very simple goal. We take complex and ever changing rules and regulations to bring you awareness and practical tools that can help you understand and enhance your pharmacy revenue cycle. Our website is full of resources, tools, explanations and links that can help you navigate the pharmacy revenue cycle. Each newsletter provides you with practical tips for you to put into practice.

Share Proposal to Increase CMS Coverage for Immunosuppressive Drugs following Transplants under Part B to Lifetime Coverage

Sign up to save your podcasts

Proposal to Increase CMS Coverage for Immunosuppressive Drugs following Transplants under Part B to Lifetime Coverage

Proposal to Increase CMS Coverage for Immunosuppressive Drugs following Transplants under Part B to Lifetime Coverage